VettedRx

Overview

Wellth uses behavioral economics and daily financial incentives (loss aversion) delivered via smartphone check-ins to improve medication adherence and care plan compliance, primarily for health plans and at-risk providers with pharma-adjacent applications. Founded in 2014.

Notable

$20M Series B (2023); early backing from Boehringer Ingelheim Venture Fund; published Medicaid adherence outcomes.

Key services

  • incentive-based medication adherence programs
  • daily photo check-in verification
  • chronic condition engagement
  • adherence analytics

Subcategories

Verified Reviews

No verified reviews yet — are you a customer of Wellth? Share your experience in a short, confidential interview.

Share your experience

Sources